0001104659-22-110047.txt : 20221019
0001104659-22-110047.hdr.sgml : 20221019
20221019184945
ACCESSION NUMBER: 0001104659-22-110047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221017
FILED AS OF DATE: 20221019
DATE AS OF CHANGE: 20221019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hinshaw William
CENTRAL INDEX KEY: 0001774662
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38901
FILM NUMBER: 221319468
MAIL ADDRESS:
STREET 1: C/O AXCELLA HEALTH INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axcella Health Inc.
CENTRAL INDEX KEY: 0001633070
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: THIRD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-868-0949
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: THIRD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Pronutria Biosciences, Inc.
DATE OF NAME CHANGE: 20150206
4
1
tm2228585-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-10-17
0
0001633070
Axcella Health Inc.
AXLA
0001774662
Hinshaw William
C/O AXCELLA HEALTH INC.
840 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
1
0
0
President & CEO
Common Stock
2022-10-17
4
A
0
50000
A
98012
D
Common Stock
2022-10-19
4
S
0
16000
1.5642
D
82012
D
On September 29, 2020, the Reporting Person was granted 50,000 restricted stock units ("RSUs"), which vest upon satisfaction of certain performance criteria. On October 17, 2022, the Issuer's Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such RSUs.
Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.52 to $1.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
By: /s/ Paul Fehlner, Attorney-in-Fact
2022-10-19